Gapping up
In reaction to earnings/guidance:
- ZM +30%, GRAF +5.2%, RXT +3.7%, COHU +2.2%
Other news:
- KODK +46.1% (D.E. Shaw discloses 5.2% passive stake)
- PRTH +35.9% (to acquire Priority's RentPayment business; expected to close in the third quarter of 2020)
- GOGO +24.1% (Intelsat to acquire Gogo's Commercial Aviation Business for $400 mln in cash )
- ATNX +23.2% (FDA has accepted for filing the Company's NDA for oral paclitaxel and encequidar for the treatment of metastatic breast cancer and has granted the application Priority Review)
- TTOO +14.1% (receives FDA Emergency Use Authorization for T2SARS-CoV-2 Panel)
- WPRT +11.8% (awarded electronics supply contract from "tier one" automotive supplier)
- MNOV +8.8% (provides update on development progress on intranasal formulation of SARS-CoV-2 vaccine for COVID-19)
- FLR +3.3% (highlights US Nuclear Regulatory Commission design certification)
- SVM +2.9% (reports 18% increase in silver resources at Ying property)
- NVS +2.9% (reports it completed enrollment in the CAN-COVID Phase III clinical trial with expected readout in Q4)
- WMT +2.7% (officially rolls out Walmart+)
- LBRT +2.2% (Liberty Oilfield Services and Schlumberger (SLB) announce agreement for the contribution of Schlumberger's onshore hydraulic fracturing business in US/Canada)
- UBX +1.9% (new CFO)
- GME +1.9% (RC Ventures increased active stake to 9.6%)
- OESX +1.9% (provided additional detail regarding a turnkey LED lighting retrofit project for a new customer, a large specialty retailer)
- CPG +1.7% (raises FY20 production guidance)
Analyst comments:
- NPTN +8.9% (upgraded to Buy from Neutral at B. Riley FBR)
- BLMN +6.7% (upgraded to Strong Buy from Outperform at Raymond James)
- GLOG +5.4% (upgraded to Buy from Hold at DNB Markets)
- CMPI +3.9% (initiated with a Neutral at BofA Securities)
- ZEN +3.8% (upgraded to Overweight from Neutral at Piper Sandler)
- QCOM +2.4% (upgraded to Equal Weight from Underweight at Wells Fargo)
- FRLN +2.4% (initiated with an Overweight at Morgan Stanley)
- TGTX +2.4% (initiated with an Overweight at JP Morgan)